Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users
- 23 February 2006
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 15 (10) , 710-718
- https://doi.org/10.1002/pds.1226
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Longitudinal patterns in the prevention of osteoporosis in glucocorticoid‐treated patientsArthritis & Rheumatism, 2005
- The impact of compliance with osteoporosis therapy on fracture rates in actual practiceOsteoporosis International, 2004
- Statistical Methods for Rates and ProportionsPublished by Wiley ,2003
- Management of glucocorticoid‐induced osteoporosis in patients with rheumatoid arthritis: Rates and predictors of care in an academic rheumatology practiceArthritis & Rheumatism, 2002
- Prevention of Glucocorticoid-Induced OsteoporosisArchives of internal medicine (1960), 2001
- Quality of Medical Care Delivered to Medicare BeneficiariesJAMA, 2000
- Quality of Care for Patients With Rheumatoid ArthritisJAMA, 2000
- Demographics, health behaviors, and past drug use as predictors of recall accuracy for previous prescription medication useJournal of Clinical Epidemiology, 1997
- Validation of pharmacy records in drug exposure assessmentPublished by Elsevier ,1997
- Recall Accuracy for Prescription Medications: Self-report Compared with Database InformationAmerican Journal of Epidemiology, 1995